Colorectal cancer (metastatic) - aflibercept: evaluation report
Contents:
01 NICE's response to comments on the Appraisal Consultation Document (ACD)
02 Consultee comments on the ACD - Sanofi
03 Consultee comments on the ACD - Royal College of Nursing
04 Consultee comments on the ACD - Department of Health
05 Expert comments on the ACD - Adams
06 Public comments on the ACD received via the NICE website
07 Evidence Review Group Commentary
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
Colorectal cancer (metastatic) - aflibercept: evaluation report
22 August 2014 (509.46 Kb 28 sec) |
This page was last updated: 21 August 2014